Abstract Enteropathogenic Escherichia coli (EPEC) expressing the Type III secretion system (TTSS) induced hemolysis of sheep blood cells. Using this assay, six structurally related compounds designated as guadinomines were isolated as inhibitors of TTSS-induced hemolysis by ion exchange column chromatography and HPLC from the culture broth of Streptomyces sp. K01-0509. Guadinomines A and B showed potent inhibition with IC 50 values of 0.02 and 0.007 m g/ml, respectively, guadinomine D showed moderate activity (IC 50 : 8.5 mg/ml), while guadinomines C 1 and C 2 and guadinomic acid had no activity.
Introduction
Our research group has focused on the discovery of antiinfectives from microbial metabolites [1ϳ3] . The Type III secretion system (TTSS) is a common virulence system present in many Gram-negative bacteria, including Yersinia spp., Salmonella spp., Shigella spp., Pseudomonas aeruginosa, EPEC, enterohemorragic E. coli (EHEC), and Chlamydia spp. [4] . These bacteria use TTSS to deliver effector proteins into the cytosol of the eukaryotic target cell and depend on their respective TTSS to invade the host, resist phagocytosis, grow in deep tissues, and cause disease [5] . Recent studies have revealed that TTSS is not essential for the survival of bacteria and is not found in non-pathogenic Gram-negative bacteria except for some kinds of symbiotic bacteria.
Based on the new concept of "anti-infective drugs" developed by Ō mura [6] , we have focused on TTSS as a new target for anti-infective drugs. Namely, a specific inhibitor of TTSS is expected to attenuate pathogens specifically and inhibit the process of their infection without killing pathogens and affecting normal bacterial flora. And such a specific agent would be expected to target the system only involved in the virulence mechanism. Thus, there would be little or no selective pressure for viability, potentially reducing the development of resistance. A convenient assay system in screening for TTSS inhibitors from microbial metabolites was employed using TTSS-induced hemolysis [7] . As a part of this screening program, we discovered six novel compounds designated guadinomines A to D and guadinomic acid ( Fig.  1) , produced by actinomycete strain K01-0509. The structure elucidation of these guadinomines will be ORIGINAL ARTICLE Guadinomines, Type III Secretion System Inhibitors, Produced by Streptomyces sp. K01-0509 published in an accompanying study [8] . In this study, the taxonomy, fermentation, isolation, and biological properties of guadinomines are described.
Materials and Methods

Taxonomic Studies
The International Streptomyces Project (ISP) media recommended by Shirling and Gottlieb [9] and media recommended by Waksman [10] were used to investigate the cultural and physiological characteristics. Cultures were routinely observed after incubation for two weeks at 27°C. The utilization of carbon sources was tested by growth on Pridham and Gottlieb's medium containing 1.0% carbon at 27°C [11] . Morphological properties were observed with a scanning electron microscope (model JSM-5600, JEOL). The type of diaminopimelic isomers present was determined by the method of Becker et al. [12] . Menaquinones were extracted and purified after Collins et al. [13] , then analyzed by high performance liquid chromatography (HPLC) equipped with a CAPCELL PAK C18 column (Shiseido) [14] .
Fermentation
Strain K01-0509 was grown and maintained on an agar slant consisting of 1.0% starch, 0.3% NZ amine, 0.1% yeast extract, 0.1% meat extract, 1.2% agar and 0.3% CaCO 3 . A loopful of spores of Streptomyces sp. K01-0509 was inoculated into 100 ml of the seed medium consisting of 2.4% starch, 0.1% glucose, 0.3% peptone, 0.3% meat extract, 0.5% yeast extract and 0.3% CaCO 3 (adjusted to pH 7.0 before sterilization) in a 500-ml Erlenmeyer flask. The inoculated flask was incubated in a rotary shaker (210 rpm) at 27°C for 3 days.
For production of guadinomines A, B and D, a 1-ml portion of the seed culture was transferred to a 500-ml Erlenmeyer flask (total 49 flasks) containing 100 ml of production Medium A (2.0% galactose, 2.0% dextrin, 0.5% corn steep liquor, 1.0% Bacto-soytone, 0.2% (NH 4 ) 2 SO 4 and 0.2% CaCO 3 (adjusted to pH 7.4 before sterilization)) and fermentation was carried out in a rotary shaker (210 rpm) at 27°C for 9 days.
For production of guadinomines C 1 and C 2 , the seed culture (200 ml) was transferred to a 30-liter Jar fermentor (total of three fermentors) containing 20 For production of guadinomic acid, a 1-ml portion of the seed culture was transferred to a 500-ml Erlenmeyer flask (total 42 flasks) containing 100 ml of production Medium B and fermentation was carried out in a rotary shaker (210 rpm) at 27°C for 6 days.
The time courses of inhibitory activity against TTSS by the supernatant of the culture broth (0.5 ml), the pH of the culture and packed cell volume (PCV, ml/10 ml) after centrifugation (3,000 rpm, 10 minutes) of the culture (10 ml) during fermentation were measured.
Assay of TTSS Activity TTSS activity was measured as the hemolytic activity caused by TTSS of EPEC in a 96-well microplate as reported previously [7] . TTSS-expressing EPEC and erythrocytes were mixed and the hemolytic activity was measured spectrometrically. Namely, noninfectious strain EPEC DCesT, which was defective of the chaperon protein of Tir (translocated intimin receptor), was used in this assay. One loopful of this strain was inoculated in liquid medium (5.0 ml) consisting of 2.5% LB medium (Funakoshi Co. Ltd., Japan) and cultured at 37°C for 12 hours without shaking. The seed culture (1.0%) was transferred to M9 medium (0.4% glucose, 0.1% casamino acids, 0.68% Na 2 HPO 4 , 0.3% KH 2 PO 4 , 0.05% NaCl, 0.1% NH 4 Cl and 0.012% MgSO 4 ), and the main culture was incubated at 37°C for 4.5 hours without shaking. The culture was centrifuged at 3,000 rpm for 15 minutes to collect the bacterial cells, which were suspended in M9 medium (5.0 ml) and used as TTSS-expressing EPEC. In parallel, sheep blood cells (Nippon Biological Materials Center, Japan) were washed three times by suspension in saline and centrifugation at 2,500 rpm for 5 minutes. The red cells (1.0 g), suspended in M9 medium (2 ml), were used as erythrocytes. Then, a test sample dissolved in M9 medium (10 m l), TTSS-expressing EPEC (45 m l) and erythrocytes (45 ml) were added to each well of a 96-well microplate (Corning). The microplate was centrifuged at 1,500 rpm for 10 minutes to make EPEC and erythrocytes come into contact, and was incubated at 37°C for 90 minutes to promote the hemolytic reaction, which was stopped by adding cooled PBS (150 ml/well). The mixture was centrifuged at 1,500 rpm for 10 minutes, and the supernatant (100 m l) was transferred to a 96-well microplate to measure the hemolytic activity by determining the absorbance at 550 nm with a microplate reader (Bio-Instruments Inc., U.S.A.). In control experiments (no drug) an absorbance of 0.3ϳ0.5 at 550 nm was obtained as a full hemolytic activity induced by TTSSexpressing EPEC.
Assay of Antibacterial Activity
Antimicrobial activity was measured by a paper disk method (6 mm, ADVANTEC) [15] 
Assay of Cytotoxic Activity
Cytotoxic activity against Jurkat cells was measured using the colorimetric 3-(4,5-dimethylthiazo-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay in a 96-well microplate [16] . Jurkat cells growing exponentially in RPMI-1640 (4ϫ10 5 cells/ml; 50 m l) and drugs in RPMI-1640 containing 1.0% DMSO (50 ml) were added to each well of a 96-well microplate and were then cultured at 37°C for 48 hours in a 5.0% CO 2 atmosphere. After incubation, MTT in phosphate buffered saline (5.5 mg/ml; 10 ml) was added to each well, followed by further incubation at 37°C for 4 hours. A 90-m l aliquot of extraction solution (40% (v/v) N,N-dimethylformamide, 2.0% (v/v) CH 3 COOH, 20% (w/v) SDS and 0.03 N HCl) was added and the mixtures were shaken at room temperature for 2 hours. Cytotoxic activity was determined by measuring optical density at 550 nm with a microplate reader (BIO-TEK Instruments).
Results
Taxonomy of the Producing Strain K01-0509
Strain K01-0509 was isolated from a soil sample collected at Amamioshima, Kagoshima, Japan. The vegetative mycelia grew abundantly on yeast extract -malt extract agar, oatmeal agar, inorganic salt -starch agar, glycerolasparagine agar and glucose-asparagine agar, and did not show fragmentation into coccoid forms or bacillary elements. The color of vegetative mycelia was yellow to brown. The aerial mycelia grew abundantly on yeast extract-malt extract and glycerol -asparagine agar and the aerial mass color was white to gray. From observation of the scanning electron micrograph of the strain (Fig. 2) , the spore chains were straight and with more than 20 spores per chain. The spores were cylindrical in shape, 0.6ϳ0.8ϫ1.0ϳ1.8 m m in size and had a smooth surface. Whirls, sclerotic granules, sporangia and flagellate spores were not observed. The growth temperature range was 10ϳ38°C. D-Glucose and L-arabinose were used as the sole carbon source and D-fructose, myo-inositol, D-mannitol, melibiose, raffinose, L-rhamnose, sucrose and xylose were not used. Melanoid pigment was produced in tryptone - yeast extract broth. No soluble pigment was found. The isomer of DAP in whole-cell hydrolysates of strain K01-0509 was determined to be an LL-form. Major menaquinones were MK-9 (H 6 ) and MK-9 (H 8 ). Based on the taxonomic properties described above, strain K01-0509 is considered to belong to the genus Streptomyces [17] and was deposited at the National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology Japan, as FERM BP-08504.
Fermentation
Typical time courses of the fermentation for production of guadinomines A, B and D in Medium A and for production of guadinomines C 1 and C 2 and guadinomic acid in Medium B in a 500-ml Erlenmeyer flask are shown in Fig.  3a and 3b, respectively. In Medium A the inhibitory activity of the culture broth against TTSS reached maximum levels on day 2ϳ3 after inoculation and then slowly decreased.
Isolation
The procedure for the isolation of guadinomines A, B and D is summarized in Scheme 1. The 9-day old culture broth (Medium A, 4.9 liters) was extracted with 5.0 liters of Me 2 CO, followed by centrifugation at 3,000 rpm to separate the mycelium and the supernatant. The supernatant was concentrated under reduced pressure to remove Me 2 CO and then passed through a Dowex 50W x2 [H + ] column (100 i.d.ϫ100 mm, Muromachi Technos Co.) previously activated. After washing with water (900 ml), the active materials were eluted with 1.5 N NH 4 OH (900 ml), followed by neutralization by HCl and desalting by a micro acylizer (Asahi Chemical Co.). The whole eluate was concentrated in vacuo and lyophilized to yield a brown material (1.1 g). The material was dissolved in a small amount of 0.05 M CH 3 COONH 4 buffer (pH 3.7) and applied to a Toyopearl SP650-C column (60 i.d.ϫ110 mm, Tosoh Co.) previously equilibrated with 0.05 M CH 3 COONH 4 buffer (pH 3.7). After washing with 0.05, 0.1 and 0.2 M CH 3 COONH 4 buffer (pH 3.7, 900 ml each), the active materials were eluted with 0.2, 0.4 and 0.6 M CH 3 COONH 4 buffer (pH 3.7, 900 ml each). The 0.4 and 0.6 M CH 3 COONH 4 fractions were neutralized by NH 4 OH. desalted by a micro acylizer and concentrated in vacuo to dryness to yield a brown material (396 mg). The material was dissolved in a small amount of water and purified by HPLC on a Develosil C 30 column (20 i.d.ϫ250 mm, Nomura Chemical Co.) with 15% aq MeOH/0.1% TFA at 7.0 ml/minute detected at UV 210 nm. The retention times of guadinomines A and B were 27 and 30 minutes, respectively (Fig. 4a) . Each active fraction was concentrated in vacuo to dryness to afford guadinomine A (3.3 mg) and guadinomine B (5.5 mg) as pale brown powders. In contrast, the 0.2 M CH 3 COONH 4 fraction was neutralized by NH 4 OH, desalted by a micro acylizer and concentrated in vacuo to dryness to yield a brown material (708 mg). This material was dissolved in a small amount (Fig. 4b) . The active fraction was concentrated in vacuo to dryness to afford guadinomine D (21.9 mg) as a pale brown powder.
The procedure for the isolation of guadinomines C 1 and C 2 guided by detection of Fearon reagent (positive for guanidine moieties) [18] is summarized in Scheme 2. The 4-day old culture broth (Medium B, 90 liters) was centrifuged at 3,000 rpm to separate the mycelium and the supernatant. The supernatant (54 liters) was passed through a column of active charcoal (100 i.d.ϫ80 mm) previously activated. After washing with water (1,500 ml), the active materials were eluted with 20 and 40% aq Me 2 CO (1,500 ml each). The whole eluate was concentrated in vacuo and lyophilized to yield a brown material (21.5 g). The active material was dissolved in a small amount of water and applied on a IRC-50 [H ϩ ] column (80 i.d.ϫ60 mm, Organo Co.) previously activated. After washing with water (900 ml), the active materials were eluted with 1.0 N HCl (900 ml) followed by neutralization by NaOH and desalting by a micro acylizer. The whole eluate was concentrated in vacuo and lyophilized to yield a brown material (823 mg). The material was dissolved in a small amount of water and applied to an ODS column (10 i.d.ϫ40 mm, Senshu Scientific Co.) previously equilibrated with water. After washing with water (10 ml), the active materials were eluted with 10 and 20% MeOH/0.1% TFA (10 ml each). The whole eluate was concentrated in vacuo to dryness to yield a brown material (103 mg). The material was dissolved in a small amount of water and purified by HPLC on a Develosil C 30 column (20 i.d.ϫ250 mm) with 8.0% MeOH/0.1% TFA at 5.0 ml/minute detected at UV 210 nm. The active fraction with a retention time of 45 minutes was concentrated in vacuo to dryness to yield a pale brown material (3.6 mg). The material was dissolved in a small amount of water and finally purified by HPLC on a Develosil C 30 column (20 i.d.ϫ250 mm) with 3.0% CH 3 CN/0.05% H 3 PO 4 at 5.0 ml/minute detected at UV 210 nm. The active fractions with retention times of 27 and 30 minutes (Fig. 5) were concentrated in vacuo to dryness to afford guadinomine C 1 (1.1 mg) and guadinomine C 2 (1.5 mg) as white powders, respectively. The procedure for the isolation of guadinomic acid guided by detection of Fearon reagent (positive for guanidine moieties) is summarized in Scheme 3. The 6-day old culture broth (Medium B, 4.2 liters) was centrifuged at 3,000 rpm to separate the mycelium and the supernatant. The supernatant (3.5 liters) was passed through a cation exchange Dowex 50W x2 [H ϩ ] column (60 i.d.ϫ40 mm) previously activated. After washing with water (500 ml), the materials were eluted with 1.5 N NH 4 OH (300 ml) followed by neutralization by NaOH and desaltation by The detailed conditions of HPLC are described in the "Results".
Scheme 2 Isolation procedure of guadinomines C 1 and C 2 micro acylizer. The whole eluate was concentrated in vacuo and lyophilized to yield a brown material (800 mg). The material was dissolved in 10 ml of methanol and centrifuged at 3,000 rpm. The supernatant (413 mg) was applied to an ODS column (25 i.d.ϫ165 mm) previously equilibrated by water. The materials were eluted with water (200 ml). The whole eluate was concentrated in vacuo and lyophilized to yield a brown material (38.2 mg). The material was dissolved in a small amount of water and purified by HPLC on a PEGASIL ODS column (20 i.d.ϫ250 mm, Senshu Scientific Co.) with 2.0% aq MeOH at 8.0 ml/minute detected at UV 210 nm. The fraction with a retention time of 16 minute (Fig. 6 ) was collected and concentrated in vacuo to dryness to afford guadinomic acid (4.3 mg) as a white powder.
Biological Activities
As shown in Fig. 7 , guadinomines A, B and D showed dose-dependent inhibition of EPEC-induced hemolysis, suggesting that these compounds inhibited TTSS. Among them, guadinomine B was the most potent with an IC 50 value of 0.007 m g/ml, followed by guadinomine A (IC 50 : 0.02 m g/ml). Guadinomine D was a moderate inhibitor (IC 50 : 8.5 m g/ml). However, guadinomines C 1 and C 2 and guadinomic acid showed no activity at 100 m g/ml in this assay. All guadinomines and guadinomic acid showed no antimicrobial activity against yeasts, fungi and Grampositive and Gram-negative bacteria at 10 mg/6 mm disk by the paper disk method. Guadinomine B showed cytotoxic activity against Jurkat cells with IC 50 of 6.1 mg/ml. This is 100 times higher than the inhibitory activity against EPECinduced hemolysis. Under the same condition, tetracycline inhibited EPEC-induced hemolysis with IC 50 of 2.0 mg/ml and also showed antimicrobial activity against EPEC (inhibition zone, 19 mm at 10 mg/6 mm disk).
Discussion
Several compounds have been reported as TTSS inhibitors The detailed conditions of HPLC are described in the "Results".
Scheme 3 Isolation procedure of guadinomic acid ( Fig. 8) . The natural products caminosides were isolated from the marine sponge Caminus sphaeroconia in a screen system in which Esp proteins secreted from EPEC were detected by SDS-PAGE [19] . Caminoside A showed TTSS inhibition with IC 50 of 38.5 m g/ml. Lactoferrin, a highmolecular weight glycoprotein, was reported to inhibit EPEC-induced hemolysis with an IC 50 value of 3.0 mg/ml because of hydrolysis of TTSS proteins [20] . Three synthetic compounds are also known to be TTSS inhibitors. The first compound having a salicylideneaniline substructure was reported to reduce the amount of Type III secretion proteins, Tir and EspB, with IC 50 of 5.1 m g/ml [21] . The second compound having an amide bond and a Shiff-base substructure inhibited the transcription of the TTSS-related proteins in Yersinia spp. with an IC 50 of 2.2 m g/ml [22] . The third azole compound inhibited the transcription of the TTSS-related proteins, SopE, SipB and ExoU, in Pseudomonas murine with IC 50 values of 1.9ϳ80 m g/ml [23] . Thus, guadinomines are the first microbial metabolites inhibiting TTSS. Among the inhibitors listed, guadinomines A and B appear to be the most potent TTSS inhibitors reported to date with IC 50 values of 0.007ϳ0.01 mg/ml although the other inhibitors could not be evaluated in our assay system. Therefore, it would be useful to examine the mode of action of guadinomines in the inhibition of EPEC-induced hemolysis. TTSS inhibitors are expected to treat not only diarrhea caused by EPEC but various diseases caused by Gram-negative pathogenic bacteria.
In our assay system, guadinomines A and B showed much more potent inhibitory activity against TTSS than guadinomine D, while guadinomines C 1 and C 2 showed no activity, indicating that diamino groups are important for the activity. Furthermore, guadinomic acid had no activity, indicating that the cyclic guanidine moiety alone is not sufficient for activity.
As shown in Fig. 7 , tetracycline inhibited EPEC-induced hemolysis by prevention of TTSS protein synthesis and also showed anti-EPEC activity. In contrast, guadinomines markedly inhibit EPEC-induced hemolysis with no anti-EPEC activity. 
